Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07ESH
|
||||
Former ID |
DCL000594
|
||||
Drug Name |
PF-1913539
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease; Huntington's disease [ICD9: 331, 294.1, 333.4; ICD10:G30, F02.2, G10] | Discontinued in Phase 3 | [548096] | ||
Company |
Pfizer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H15N7O
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CCN2C3=C(C=N2)C4=NC(=NN4C(=N3)N)C5=CC=CO5
|
||||
InChI |
1S/C18H15N7O/c19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14/h1-7,10-11H,8-9H2,(H2,19,22)
|
||||
InChIKey |
UTLPKQYUXOEJIL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980583, 10258377, 14900558, 26753254, 33500024, 47510090, 47731275, 50068074, 57395307, 76160696, 85209294, 85286114, 85788185, 90341001, 91746416, 99431535, 103180831, 103978930, 104425548, 121362004, 126671705, 129418187, 134339148, 134340512, 134341517, 135153621, 135651030, 135651205, 135697574, 142362474, 144240144, 144240145, 162023190, 162223707, 163124439, 163565213, 164759434, 170474553, 175612758, 176225385, 179294000, 184538735, 196376772, 198945991, 202558330, 204360450, 215780619, 223454701, 223519245, 223660679
|
||||
Target and Pathway | |||||
Target(s) | Metabotropicglutamate receptor 1 | Target Info | Antagonist | [535907], [549974] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.